Bayer Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases

[PR Newswire] – WHIPPANY, N.J., Feb. 20, 2014 /PRNewswire/ — Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga ® (regorafenib) tablets in colorectal cancer … more

View todays social media effects on AMGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Amgen is hiring next, click here to view